Review
Published on 12 Aug 2024
Biological functions and therapeutic potential of CKS2 in human cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1424569
- 742 views
Type at least 3 characters
1,766 articles
Articles
Original Research
Published on 09 Aug 2024
Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1447807
- 1,156 views
Review
Published on 07 Aug 2024
The mechanism of ITGB4 in tumor migration and invasion
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1421902
- 1,504 views
Hypothesis and Theory
Published on 06 Aug 2024
Integrating electromagnetic cancer stress with immunotherapy: a therapeutic paradigm
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1417621
- 1,552 views
Mini Review
Published on 05 Aug 2024
Epigenetic regulation of NKG2D ligand and the rise of NK cell-based immunotherapy for cancer treatment
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1456631
- 1,281 views
Review
Published on 02 Aug 2024
Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1441222
- 1,687 views
Review
Published on 01 Aug 2024
The emerging role of osteoclasts in the treatment of bone metastases: rationale and recent clinical evidence
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1445025
- 992 views
Case Report
Published on 25 Jul 2024
Denosumab combined with chemotherapy followed by anlotinib in the treatment of multiple metastases of malignant peripheral nerve sheath tumor: a case report and literature review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1399021
- 758 views
Original Research
Published on 25 Jul 2024
Trabectedin may be a valuable treatment option for elderly patients with metastatic soft tissue sarcomas
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1437732
- 778 views
Review
Published on 18 Jul 2024
Preclinical models for the study of pediatric solid tumors: focus on bone sarcomas
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1388484
- 1,061 views
Original Research
Published on 18 Jul 2024
Type II mode of JAK2 inhibition and destabilization are potential therapeutic approaches against the ruxolitinib resistance driven myeloproliferative neoplasms
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1430833
- 1,392 views
Original Research
Published on 17 Jul 2024
The landscape of cancer-associated transcript fusions in adult brain tumors: a longitudinal assessment in 140 patients with cerebral gliomas and brain metastases
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1382394
- 1,566 views
Review
Published on 17 Jul 2024
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1427802
- 2,558 views
Review
Published on 12 Jul 2024
Molecular characteristics and immune microenvironment of gastrointestinal stromal tumours: targets for therapeutic strategies
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1405727
- 853 views
Original Research
Published on 12 Jul 2024
Phase Ib and pharmacokinetics study of alpelisib, a PIK3CA inhibitor, and capecitabine in patients with advanced solid tumors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1390452
- 1,259 views
Mini Review
Published on 11 Jul 2024
Unveiling the role of O(6)-methylguanine-DNA methyltransferase in cancer therapy: insights into alkylators, pharmacogenomics, and others
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1424797
- 676 views